πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 54 of 200 Β· A–Z by INN

  1. dextran-70 + hypromellose

    POLY-TEARS Alcon Laboratories (Australia) Pty Ltd

    TGA: approved

  2. dextroamphetamine

    XELSTRYM

    TRANSDERMAL FDA: approved

  3. dextroamphetamine saccharate

    DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE

    ORAL FDA: approved

  4. dextroamphetamine sulfate

    DEXEDRINE Teva Pharma GmbH

    ORAL FDA: approved

  5. dextromethorphan hydrobromide

    NUEDEXTA Amneal Pharma Europe Ltd

    ORAL FDA: approved Β· EMA: withdrawn

    N07XX59
  6. dextromethorphan polistirex

    DEXTROMETHORPHAN POLISTIREX Amneal Pharma Europe Ltd

    ORAL FDA: approved

  7. dextrose

    DEXTROSE 60% IN PLASTIC CONTAINER Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  8. dextrothyroxine sodium

    CHOLOXIN

    ORAL FDA: approved

  9. dezocine

    DALGAN

    INJECTION FDA: approved

  10. diatrizoate meglumine

    SINOGRAFIN

    URETHRAL FDA: approved

  11. diatrizoate sodium

    MD-50

    ORAL, RECTAL FDA: approved

  12. diazepam

    ANTENEX 2 Orion Laboratories Pty.

    BUCCAL FDA: approved Β· TGA: approved

  13. diazoxide

    DIAZOXIDE Teva Pharma GmbH

    INJECTION FDA: approved

  14. diazoxide choline

    VIOKAT SOLENO THERAPEUTICS INC

    ORAL FDA: approved Β· EMA: application withdrawn

    N07X
  15. dibotermin alfa

    INDUCTOS

    EMA: approved

    M05BC01
  16. dibucaine hydrochloride

    HEAVY SOLUTION NUPERCAINE

    INJECTION FDA: approved

  17. dichlorphenamide

    ORMALVI Xeris Biopharma Holdings

    ORAL FDA: approved

  18. diclofenac

    CLONAC 25 Alphapharm Pty Ltd

    ORAL FDA: approved Β· TGA: approved Β· NMPA: clinical trials

  19. diclofenac epolamine

    LICART

    TOPICAL FDA: approved

  20. diclofenac potassium

    DICLOFENAC POTASSIUM Teva Pharma GmbH

    ORAL FDA: approved

  21. diclofenac sodium

    DICLOFENAC SODIUM Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved

  22. diclofenamide

    EKESIVY

    EMA: application withdrawn

    S01EC02
  23. dicloxacillin

    DISTAPH 500 Alphapharm Pty Ltd

    TGA: approved

  24. dicloxacillin sodium

    PATHOCIL Teva Pharma GmbH

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources